Tirzepatide is the active ingredient in Zepbound and Mounjaro, and the trial results behind it are strong [1]. Compounded tirzepatide is a pharmacy-made copy of that molecule. It hasn’t been through a trial of its own, and FDA doesn’t check it before it ships [8]. So the honest answer to “does it work?” has two halves: the molecule does, and whether your vial delivers it is a separate question.
Tirzepatide works: the trial numbers
In the main weight trial, weekly tirzepatide produced 15.0%, 19.5% and 20.9% average weight loss at 5, 10 and 15 mg, against 3.1% on placebo, after 72 weeks [1]. That study enrolled adults with obesity or overweight who didn’t have type 2 diabetes.
Two more trials fill in the picture. In SURMOUNT-5, tirzepatide beat semaglutide head to head: 20.2% weight loss against 13.7% at 72 weeks [2]. In SURPASS-2, people with type 2 diabetes saw their A1C fall by 2.01 to 2.30 percentage points over 40 weeks, more than on semaglutide 1 mg [4]. All three were funded by Lilly and used Lilly’s manufactured drug.
No trial has tested a compounded product
Every number above comes from Lilly’s drug. No published controlled trial has tested a compounded tirzepatide product against placebo or against Zepbound.
A 2025 opinion from a pharmacist group at the American College of Clinical Pharmacy put it plainly. It found “limited data demonstrating positive clinical outcomes in small cohorts of patients receiving compounded semaglutide and tirzepatide” [5]. The same group urged prescribers to help patients get approved drugs where they can, and to monitor anyone on a compounded one.
FDA’s own position is the reason the gap matters. Compounded drugs “are not FDA approved,” which means the agency “does not review compounded drugs for safety, effectiveness or quality before they are marketed” [8].
| Question | Tested on approved tirzepatide? | Tested on compounded tirzepatide? | Source |
|---|---|---|---|
| Weight loss vs placebo | Yes: 15.0% to 20.9% at 72 weeks | No controlled trial | SURMOUNT-1 [1] |
| Weight loss vs semaglutide | Yes: 20.2% vs 13.7% | No controlled trial | SURMOUNT-5 [2] |
| Blood sugar in type 2 diabetes | Yes: A1C down 2.01 to 2.30 points | No controlled trial | SURPASS-2 [4] |
| Sleep apnea | Yes: Zepbound is approved for it | No controlled trial | Zepbound label [9] |
| Weight kept off with continued use | Yes: a further 5.5% lost from week 36 to 88 | No controlled trial | SURMOUNT-4 [3] |
| Regain after stopping | Yes: 14.0% regained on placebo | No controlled trial | SURMOUNT-4 [3] |
| Clinical outcomes in practice | Not applicable | Small groups of patients only | ACCP opinion, 2025 [5] |
The compounded column is close to empty, and that is the finding that matters for anyone choosing a compounded product.
Same molecule doesn’t guarantee the same result
A compounded product reproduces the trial results only if it holds the right molecule at the labeled strength and is stored and dosed as intended. Each of those links can break, and FDA has documented several of them.
| Risk | What FDA or a study reported | What you can check |
|---|---|---|
| Strength not verified | FDA doesn’t review compounded drugs for quality before sale [8] | Ask which licensed pharmacy makes it |
| Doses beyond the label | FDA has adverse-event reports tied to compounded doses beyond the approved label, or raised faster [8] | Ask your prescriber how your dose compares with the label |
| Add-ins such as B12 | Lilly scientists reported a new tirzepatide–B12 impurity in mass-compounded products; its clinical effects are unknown [6] | Ask whether your product is plain tirzepatide |
| Warm delivery | FDA advises against using any injectable GLP-1 that arrives warm [8] | Check that it ships cold |
| Unlicensed supplier | 4 of 21 supplier facilities in a 2026 study weren’t licensed for sterile compounding [7] | Ask for the pharmacy’s name and license |
The B12 impurity paper was written entirely by Eli Lilly employees. Lilly makes Zepbound and Mounjaro.
The dosing point deserves a second look. FDA describes adverse events in people prescribed compounded tirzepatide “in doses beyond what is in the FDA-approved drug label,” which “could mean using more product in a single dose, taking doses more frequently or increasing the amount more quickly” [8]. A product that’s dosed differently from the trials can’t borrow the trials’ results.
Add-ins are the other common gap. In a 2026 secret-shopper study of clinics and med spas in two states, 56.0% offered a GLP-1 with B vitamins [7]. No trial shows that adding B12 or glycine improves weight loss.
Is it as effective as Mounjaro or Zepbound? Nobody has measured it
No study has compared compounded tirzepatide with Zepbound or Mounjaro, so the honest answer is that nobody knows. That cuts both ways. There’s no evidence it works less well when the product is right, and no evidence it works as well. The compounded tirzepatide vs Zepbound comparison covers price, form and access side by side.
Prescribers judge it over months, not weeks
Prescribers judge response by your weight trend and side effects over months at a steady dose, not by the first few weeks. Zepbound’s label starts every patient at 2.5 mg, a dose meant to begin treatment rather than to keep you on, and allows up to 15 mg a week [9]. Early weeks on a starting dose aren’t a fair test of whether the drug is working.
Signs worth raising with your prescriber include no change in appetite or weight after you’ve reached a maintenance dose, or side effects much stronger than expected. Either can point to a product problem as easily as a dose question. Don’t change your dose on your own; the label sets the dose ranges for the approved drug, and your prescriber sets yours.
Most of the weight comes back after stopping
In SURMOUNT-4, everyone took tirzepatide for 36 weeks first. Those then switched to placebo regained 14.0% of their weight by week 88, while those who stayed on lost a further 5.5% [3]. Plan for tirzepatide as a long-term treatment, whichever product you use.
How to get a product most likely to match the trials
The checks that matter are a named, licensed pharmacy, plain tirzepatide with no add-ins, cold delivery and a prescriber who follows up. Some programs make the first check easy: Eden, Embody and Midi Health name the pharmacy that fills their tirzepatide on their own pages.
- Ask which pharmacy compounds it, and check that it’s licensed in your state.
- Ask whether the product is plain tirzepatide or carries an add-in.
- Confirm it ships with cold packs, and don’t use a dose that arrives warm.
- Ask how your dose compares with the approved label.
- Make sure a licensed clinician is available after your medicine arrives.
For the risks side of this decision, read is compounded tirzepatide safe. For where things stand legally, see is compounded tirzepatide still available. Prices are in compounded tirzepatide cost, and the where to get compounded tirzepatide guide walks through the options. 69 telehealth programs on this site prescribe tirzepatide, compared on the compounded tirzepatide scores. The same evidence question for semaglutide is answered in does compounded semaglutide work, and the molecule itself is explained on the tirzepatide page.